Thérese Sørlie

44.0k total citations · 7 hit papers
92 papers, 31.0k citations indexed

About

Thérese Sørlie is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Thérese Sørlie has authored 92 papers receiving a total of 31.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cancer Research, 51 papers in Molecular Biology and 41 papers in Oncology. Recurrent topics in Thérese Sørlie's work include Breast Cancer Treatment Studies (36 papers), Cancer Genomics and Diagnostics (27 papers) and Gene expression and cancer classification (27 papers). Thérese Sørlie is often cited by papers focused on Breast Cancer Treatment Studies (36 papers), Cancer Genomics and Diagnostics (27 papers) and Gene expression and cancer classification (27 papers). Thérese Sørlie collaborates with scholars based in Norway, United States and Sweden. Thérese Sørlie's co-authors include Per Eystein Lønning, Patrick O. Brown, Charles M. Perou, David Botstein, Hilde Johnsen, Stefanie S. Jeffrey, Matt van de Rijn, Michael B. Eisen, Anne‐Lise Børresen‐Dale and Robert Tibshirani and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Thérese Sørlie

89 papers receiving 30.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular portraits of human breast tumours

2000 11.7k citations Charles M. Perou, Thérese Sørlie et al. profile →
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2001 8.3k citations Thérese Sørlie, Charles M. Perou et al. Proceedings of the National Academy of Sciences profile →
Repeated observation of breast tumor subtypes in independent gene expression data sets

2003 4.0k citations Thérese Sørlie, Robert Tibshirani et al. Proceedings of the National Academy of Sciences profile →
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

2002 875 citations Thérese Sørlie, Charles M. Perou et al. Proceedings of the National Academy of Sciences profile →
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

2005 733 citations Howard Y. Chang, Dimitry S.A. Nuyten et al. Proceedings of the National Academy of Sciences profile →
Database of p53 gene somatic mutations in human tumors and cell lines.

1994 727 citations Thérese Sørlie et al. profile →
Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

1999 531 citations Charles M. Perou, Thérese Sørlie et al. profile →

Peers

Thérese Sørlie

ONCOL

GENET

PRM

Stefanie S. Jeffrey United States

Hilde Johnsen Norway

Anne‐Lise Børresen‐Dale Norway

Lars A. Akslen Norway

Per Eystein Lønning Norway

Jonas Bergh Sweden

Jonathan R. Pollack United States

Joel S. Parker United States

John A. Foekens Netherlands

Christos Sotiriou Belgium

Stefanie S. Jeffrey United States

Thérese Sørlie

16.6k ×1.0

14.9k ×1.0

13.8k ×0.9

ONCOL

4.7k ×1.0

GENET

3.9k ×1.0

PRM

Citations per year, relative to Thérese Sørlie Thérese Sørlie (= 1×) peers Stefanie S. Jeffrey

Countries citing papers authored by Thérese Sørlie

Since Specialization

Citations

This map shows the geographic impact of Thérese Sørlie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thérese Sørlie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thérese Sørlie more than expected).

Fields of papers citing papers by Thérese Sørlie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thérese Sørlie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thérese Sørlie. The network helps show where Thérese Sørlie may publish in the future.

Co-authorship network of co-authors of Thérese Sørlie

This figure shows the co-authorship network connecting the top 25 collaborators of Thérese Sørlie. A scholar is included among the top collaborators of Thérese Sørlie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thérese Sørlie. Thérese Sørlie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindemann, Kristina, Wanja Kildal, Andreas Kleppe, et al.. (2024). Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy. International Journal of Gynecological Cancer. 35(5). 101618–101618. 1 indexed citations

Davidson, Ben, Daniel Nebdal, Arild Holth, et al.. (2024). Endometrial carcinomas with ambiguous histology often harbor TP53 mutations. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 697–705. 1 indexed citations

Davidson, Ben, Kristina Lindemann, Bryan Fellman, et al.. (2024). Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma. Gynecologic Oncology. 189. 138–145. 1 indexed citations

Amerongen, Renée van, Mohamed Bentires‐Alj, Antonius L. van Boxtel, et al.. (2023). Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research. Journal of Mammary Gland Biology and Neoplasia. 28(1). 17–17. 3 indexed citations

Swanson, David, Tonje G. Lien, Helga Bergholtz, Thérese Sørlie, & Arnoldo Frigessi. (2019). A Bayesian two-way latent structure model for genomic data integration reveals few pan-genomic cluster subtypes in a breast cancer cohort. Bioinformatics. 35(23). 4886–4897. 5 indexed citations

Tramm, Trine, Simen Myhre, Marianne Kyndi, et al.. (2014). Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort. Clinical Cancer Research. 20(20). 5272–5280. 71 indexed citations

Sørlie, Thérese, Hilde Johnsen, Phuong Vu, et al.. (2014). Mutation Screening of the TP53 Gene by Temporal Temperature Gel Electrophoresis (TTGE). Methods in molecular biology. 1105. 315–324.

Tramm, Trine, Guido Hennig, Marianne Kyndi, et al.. (2013). Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(6). 775–786. 10 indexed citations

Zhou, Wenjing, Karin Jirström, Rose‐Marie Amini, et al.. (2013). Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study. BMC Cancer. 13(1). 512–512. 51 indexed citations

10.

Kim, Jiyoung, René Villadsen, Thérese Sørlie, et al.. (2012). Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proceedings of the National Academy of Sciences. 109(16). 6124–6129. 95 indexed citations

11.

Guiu, Séverine, Stefan Michiels, Fabrice André, et al.. (2012). Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Annals of Oncology. 23(12). 2997–3006. 221 indexed citations

12.

Borgan, Eldrid, Roy Navon, Hans Kristian Moen Vollan, et al.. (2011). Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Molecular Oncology. 5(6). 564–576. 25 indexed citations

13.

Agarwal, Roshan, Simen Myhre, Mark Carey, et al.. (2009). Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer. Clinical Cancer Research. 15(11). 3654–3662. 111 indexed citations

14.

Edgren, Henrik, Maija Wolf, Kristine Kleivi Sahlberg, et al.. (2009). Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8Ain a breast cancer cell line. BMC Medical Genomics. 2(1). 26–26. 8 indexed citations

15.

Bergamaschi, Anna, Geir Olav Hjortland, Tiziana Triulzi, et al.. (2009). Molecular profiling and characterization of luminal‐like and basal‐like in vivo breast cancer xenograft models. Molecular Oncology. 3(5-6). 469–482. 86 indexed citations

16.

Naume, Bjørn, Xi Zhao, Marit Synnestvedt, et al.. (2007). Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Molecular Oncology. 1(2). 160–171. 113 indexed citations

17.

Bergamaschi, Anna, Elda Tagliabue, Thérese Sørlie, et al.. (2007). Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. The Journal of Pathology. 214(3). 357–367. 297 indexed citations

18.

Sørlie, Thérese, Charles M. Perou, Huihui Fan, et al.. (2006). Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Molecular Cancer Therapeutics. 5(11). 2914–2918. 97 indexed citations

19.

Chang, Howard Y., Dimitry S.A. Nuyten, Julie B. Sneddon, et al.. (2005). Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proceedings of the National Academy of Sciences. 102(10). 3738–3743. 733 indexed citations breakdown →

20.

Troester, Melissa A., Katherine A. Hoadley, Thérese Sørlie, et al.. (2004). Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer. Cancer Research. 64(12). 4218–4226. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact